The aetiologies, mortality, and disability of non-traumatic coma in African children: a systematic review and meta-analysis
- PMID: 40280144
- DOI: 10.1016/S2214-109X(25)00055-5
The aetiologies, mortality, and disability of non-traumatic coma in African children: a systematic review and meta-analysis
Erratum in
-
Correction to Lancet Glob Health 2025; published online April 22. https://doi.org/10.1016/S2214-109X(25)00055-5.Lancet Glob Health. 2025 Apr 23:S2214-109X(25)00176-7. doi: 10.1016/S2214-109X(25)00176-7. Online ahead of print. Lancet Glob Health. 2025. PMID: 40286805 No abstract available.
Abstract
Background: Non-traumatic coma in African children is a common life-threatening presentation often leading to hospital attendance. We aimed to estimate the distribution of non-traumatic coma causes and outcomes, including disease-specific outcomes, for which evidence is scarce.
Methods: We systematically reviewed MEDLINE, Embase, and Scopus databases from inception to Feb 6, 2024. We included studies recruiting children (aged 1 month to 16 years) with non-traumatic coma (Blantyre Coma Scale score ≤2, ie deep coma or comparable alternative) from any African country. Disease-specific studies were included if outcomes were reported. Primary data were requested where required. We used a DerSimonian-Laird random effects model to calculate pooled estimates for prevalence of causes, mortality, and morbidity (in-hospital and post-discharge), including analysis of mortality by temporality. This study was registered with PROSPERO (CRD4202014193).
Findings: We screened 16 666 articles. 138 studies were eligible for analysis, reporting causes, outcome data, or both from 35 027 children with non-traumatic coma in 30 African countries. 114 (89%) of 128 studies were determined to be high quality. Among the causes, cerebral malaria had highest pooled prevalence at 58% (95% CI 48-69), encephalopathy of unknown cause was associated with 23% (9-36) of cases, and acute bacterial meningitis was the cause of 10% (8-12) of cases, with all other causes representing lower proportions of cases. Pooled overall case-fatality rates were 17% (16-19) for cerebral malaria, 37% (20-55) for unknown encephalopathy, and 45% (34-55) for acute bacterial meningitis. By meta-regression, there was no significant difference in cerebral malaria (p=0·98), acute bacterial meningitis (p=0·99), or all-cause coma (p=0·081) mortality by year of study. There was no substantial difference in deaths associated with cerebral malaria in-hospital compared with post-discharge (17% [16-19] vs (18% [16-20]). Mortality was higher post-discharge than in-hospital in most non-malarial comas, including acute bacterial meningitis (39% [26-52]) vs 53% [38-69]). Disability associated with cerebral malaria was 11% (9-12). Pooled disability outcomes associated with other non-malarial diseases were largely absent.
Interpretation: The prevalence and outcomes of cerebral malaria and meningitis associated with non-traumatic coma were strikingly static across five decades. Enhanced molecular and radiological diagnostics, investment, policy making, community awareness, and health service provision are all required to facilitate earlier referral to specialist centres, to drive a step-change in diagnostic yield and treatment options to improve these outcomes.
Funding: Wellcome Trust.
Translations: For the Chichewa, French and Portuguese translations of the abstract see Supplementary Materials section.
Copyright © 2025 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests DGL, MYRH, and SBG are supported by The Wellcome core award (award number 206545/Z/17/Z) to Malawi–Liverpool–Wellcome Trust. STJR and MN are also supported by Wellcome to conduct paediatric infectious diseases research (203919/Z/16/Z). STJR is also supported by a Thrasher child health early career award, Academy of Medical Sciences starter grant, and European Society of Paediatric Infectious Diseases Society diagnostic grant; and is a Centre for Human Genetics Well Institute Olink-48 grant prize winner and early research career committee member, both at The University of Oxford. MN is also supported by Roche Diagnostics for a Baby and Mother Biomarkers of Infection study; Liverpool School of Tropical Medicine as a clinical fellow for The DIAMONDS Research Consortia; FIND Diagnostics for a literature review on the utility of CRP testing in primary care in low-resource settings for supporting patient management and antibiotic stewardship; is an invited speaker at The Paediatric Infectious Diseases Games; and is deputy convenor, research co-lead, and winter meeting lead at the Royal College Of Paediatrics and Child Health's International Child Health group. MJG is supported to conduct neuroscience and infection research internationally by the Medical Research Council (MRC) Newton Fund (MR/S019960/1), MRC Developmental Pathway Funding Scheme (MR/R015406/1), and National Institute of Health and Care Research (NIHR; 153195 17/60/67, 126156 17/63/11, and 200907). CAM is a UKRI MRC Future Leaders Fellow (MR/V025856/1). TS is supported by the NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (IS-HPU-1112–10117 and NIHR200907), NIHR Global Health Research Group on Brain Infections (17/63/110), the UK MRC Global Effort on COVID-19 Programme (MR/V033441/1), the EU's Horizon 2020 research and innovation programme (ZikaPLAN; 734584), and The Pandemic Institute; receives royalties from Oxford University Press, Liverpool University Press, Cambridge University, and Elsevier for published books he has written on brain infections; co-chaired the Medicines and Healthcare Products Regulatory Agency (MHRA) Expert Working Group on COVID-19 vaccines between 2020 and 2023; was a member of the COVID-19 Vaccines Benefit Risk Expert working group for the Commission on Human Medicines (CHM) committee of MHRA between 2020 and 2023; is a Committee Member of the Wellcome Trust Pathogen Biology and Disease Transmission Discovery advisory group; was a member of the MRC's Infections and Immunity Board between 2018 and 2022; sat on the Research Excellence Framework Panel between 2021 and 2022; and was on the data safety monitoring committee of the GSK Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children (ChAd3 EBO-Z) vaccine (GSK3390107A). BDM is supported for COVID-19 neuroscience research by UK Research and Innovation (UKRI) and MRC (MR/V03605X/1); and for additional neurological inflammation due to viral infection research by grants from the MRC and UKRI (MR/V007181/1), MRC (MR/T028750/1), and the Wellcome Trust (ISSF201902/3). TTa is supported by a research grant from the US National Institutes of Health (NIH); is the President-Elect for the American Society of Tropical Medicine and Hygiene; and is a member of the Malaria Advisory Council for Novartis Pharma. GB is supported by two active and two recent research grants from US NIH; consults on educational materials for Neurotorium, Temp Traq, and similar devices at Blue Spark Technologies; lectures for The University of Calgary; participates on an advisory board for the BRIDGE clinical trial; and is on the editorial board of the Lancet Neurology, Neurotorium, and Zambian League against Epilepsy. ECG is funded by the MRC as core support to the Medical Research Council Clinical Trials Unit at University College London (MC_UU_00004/05). STJR, BDM, and TS are members of the Encephalitis International Scientific Advisory Panel—BDM is Scientific Chair and TS is President. All other authors declare no competing interests.
Similar articles
-
Aetiologies, neuroradiological features, and risk factors for mortality and long-term neurosequelae of febrile coma in Malawian children: a prospective cohort study.Lancet Glob Health. 2025 Jun;13(6):e1057-e1071. doi: 10.1016/S2214-109X(25)00054-3. Epub 2025 Apr 22. Lancet Glob Health. 2025. PMID: 40280145
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Aetiology and outcome of non-traumatic coma in African children: protocol for a systematic review and meta-analysis.Syst Rev. 2021 Oct 29;10(1):282. doi: 10.1186/s13643-021-01796-1. Syst Rev. 2021. PMID: 34715918 Free PMC article.
-
Non-traumatic coma in young children in Benin: are viral and bacterial infections gaining ground on cerebral malaria?Infect Dis Poverty. 2022 Mar 14;11(1):29. doi: 10.1186/s40249-022-00956-2. Infect Dis Poverty. 2022. PMID: 35287726 Free PMC article.
-
Childhood acute non-traumatic coma: aetiology and challenges in management in resource-poor countries of Africa and Asia.Paediatr Int Child Health. 2013 Aug;33(3):129-38. doi: 10.1179/2046905513Y.0000000068. Paediatr Int Child Health. 2013. PMID: 23930724 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical